Grace Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$848K Buy
8,200
+500
+6% +$57.9K 0.5% 58
2021
Q3
$951K Buy
7,700
+700
+10% +$90.6K 0.58% 43
2021
Q2
$869K Sell
7,000
-700
-9% -$87.9K 0.58% 50
2021
Q1
$910K Sell
7,700
-2,160
-22% -$253K 0.58% 47
2020
Q4
$1.18M Buy
9,860
+4,020
+69% +$443K 0.75% 30
2020
Q3
$606K Buy
5,840
+840
+17% +$84.4K 0.47% 56
2020
Q2
$459K Hold
5,000
0.39% 76
2020
Q1
$451K Sell
5,000
-700
-12% -$74.5K 0.44% 74
2019
Q4
$647K Hold
5,700
0.53% 48
2019
Q3
$619K Buy
5,700
+1,000
+21% +$104K 0.63% 46
2019
Q2
$458K Hold
4,700
0.22% 107
2019
Q1
$428K Sell
4,700
-700
-13% -$62.7K 0.17% 134
2018
Q4
$491K Buy
5,400
+2,400
+80% +$224K 0.23% 119
2018
Q3
$295K Hold
3,000
0.12% 139
2018
Q2
$257K Buy
+3,000
New +$251K 0.1% 158
2018
Q1
Sell
-61,784
Closed -$4.99M 93
2017
Q4
$4.99M Sell
61,784
-2,520
-4% -$202K 1.76% 24
2017
Q3
$5M Buy
64,304
+8,647
+16% +$718K 1.82% 19
2017
Q2
$4.94M Buy
55,657
+510
+0.9% +$43K 1.98% 13
2017
Q1
$4.44M Sell
55,147
-1,160
-2% -$90.6K 1.83% 17
2016
Q4
$4.01M Sell
56,307
-330
-0.6% -$25.9K 1.82% 23
2016
Q3
$4.89M Buy
56,637
+4,970
+10% +$433K 2.14% 15
2016
Q2
$4.48M Buy
51,667
+2,390
+5% +$193K 1.88% 22
2016
Q1
$3.7M Buy
49,277
+10,590
+27% +$798K 1.66% 26
2015
Q4
$2.98M Buy
+38,687
New +$2.91M 1.4% 31

Other funds holding MDT

Grace Capital's MDT Position: Q4 2021 in Review

Grace Capital increased its Medtronic (MDT) stake by 6.5% in Q4 2021, buying an estimated $57.9K and bringing the position to 8,200 shares worth $848K. The position accounts for 0.5% of the portfolio, ranked #58.

Grace Capital first reported a position in MDT in Q4 2015 and has held it in 24 quarters since. The position peaked at $5M in Q3 2017. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Grace Capital held 8,200 shares of Medtronic worth $848K as of Q4 2021.
  • Grace Capital bought 500 Medtronic shares in Q4 2021, an estimated $57.9K.
  • Medtronic made up 0.5% of Grace Capital's portfolio in Q4 2021, its #58 holding.
  • Grace Capital first reported a position in Medtronic in Q4 2015 and has held it in 24 quarters since.
  • Grace Capital's Medtronic position peaked at $5M in Q3 2017.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.